Davis AE, Brogan AJ, Goodwin B, Nocea G, Lozano V. Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV Clin Trials. 2017 Nov;18(5-6):214-22. doi: 10.1080/15284336.2017.1402144
Poulos C, Riewpaiboon A, Stewart JF, Clemens J, Guh S, Agtini M, Anh DD, Baiqing D, Bhutta Z, Sur D, Whittington D. Cost of illness due to typhoid fever in five Asian countries. Trop Med Int Health. 2011 Mar 1;16(3):314-23.
Brogan AJ, Mrus J, Hill A, Sawyer AW, Smets E. Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States. HIV Clin Trials. 2010 May;11(3):133-44.
Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav. 2009 Apr 1;34(4):365-73.
Niaura R, Shadel WG, Britt DM, Abrams DB. Response to social stress, urge to smoke, and smoking cessation. Addict Behav. 2002 Mar 1;27(2):241-50.
Cohen LM, Britt DM, Collins FL, Al'Absi M, McChargue DE. Multimodal assessment of the effect of chewing gum on nicotine withdrawal. Addict Behav. 2001 Mar 1;26(2):289-95.
Cohen LM, Collins FL, Britt DM. The effect of chewing gum on tobacco withdrawal. Addict Behav. 1997 Nov 1;22(6):769-73.